Topics:
Non-melanoma skin cancer • Rheumatology • Methotrexate • General Rheumatology • Malignancy • Dermatology
Do you continue methotrexate in patients with inflammatory arthritis who develop non-melanomatous skin cancer while on therapy?
Answer from: at Academic Institution
Data on methotrexate use and the increased risk of non-melanomatous skin cancers has been conflicting, suggesting an increased risk or a neutral risk. A recent case-control study published in the British Journal of Cancer (Polesie et al., PMID 36739322) did suggest an increased risk of both squamous...
Sign in or Register to read more